HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
418.19
+28.57 (7.33%)
At close: Jul 28, 2026, 4:00 PM EDT
418.25
+0.06 (0.01%)
After-hours: Jul 28, 2026, 7:57 PM EDT

HCA Healthcare Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Net Income
1,9301,8572,1631,9031,8911,8251,6861,4821,6871,8021,8611,2751,4121,5432,6461,3441,3791,4652,0052,472
Depreciation & Amortization
944930911889863860856842819795789769763756750749738732728716
Stock-Based Compensation
85861001049998857611287577256778387858699115
Other Adjustments
-115514-984488453555159-13-35331520094-298469-87891-142381-800-843
Change in Receivables
-954-463-43925647-327-854340-195-90-767-47468238-31060-120-427350-745
Changes in Inventories
-10680-29302-67-360150252-1457714827-87-214-112515-341-121-207-120
Changes in Accounts Payable
551-990637705324-1,00028253658-517393716561-1,066348174-47-771268682
Operating Cash Flow
2,3352,0142,3594,4164,2101,6512,5593,5151,9712,4692,6742,4792,4751,8032,5273,0201,6301,3452,4432,277
Operating Cash Flow Growth (YoY)
-44.54%21.99%-7.82%25.63%113.60%-33.13%-4.30%41.79%-20.36%36.94%5.82%-17.91%51.84%34.05%3.44%32.63%-27.59%-32.34%--16.19%

Investing Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Capital Expenditures
-1,231-1,119-1,489-1,288-1,176-991-1,285-1,191-1,281-1,118-1,159-1,147-1,241-1,197-1,323-1,131-1,080-861-1,192-889
Cash Acquisitions
-121-265-36-35-99-227-42-93-35-96-354-157-9-115-48-60-114-2-617-390
Proceeds from Business Divestments
183921061611611310101171655856326141801,950
Other Investing Activities
-22399116-751825-35-69-171-94-19-14-4-713-174-85-31
Investing Cash Flow
-1,557-1,282-1,317-1,388-1,251-1,032-1,346-1,352-1,332-903-1,597-1,312-1,257-1,151-793-546-1,205-845-1,714640

Financing Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Short-Term Debt Issued
1,2441,4352961381,5482200-850850-1,880400420-3,0801,240350-1,1603,710-2,7802,280-300
Net Short-Term Debt Issued (Repaid)
1,2441,4352961381,5482200-850850-1,880400420-3,0801,240350-1,1603,710-2,7802,280-300
Long-Term Debt Issued
2,994-3,241005,23303,01204,483423,218-211005,96670
Long-Term Debt Repaid
-2,550-58-1,555-174-1,765-3,895-64-77-203-2,066-218-83-58-550-56-84-2,624-66-82-56
Net Long-Term Debt Issued (Repaid)
444-581,686-174-1,7651,338-642,935-2032,417-214-813,160-550-35-74-2,6245,900-75-56
Repurchase of Common Stock
-2,064-1,571-2,558-2,498-2,505-2,506-1,700-1,795-1,367-1,180-910-1,140-915-846-1,519-698-2,682-2,101-2,072-2,329
Net Common Stock Issued (Repurchased)
-2,064-1,571-2,558-2,498-2,505-2,506-1,700-1,795-1,367-1,180-910-1,140-915-846-1,519-698-2,682-2,101-2,072-2,329
Common Dividends Paid
-171-183-162-166-171-180-165-169-171-185-160-162-164-175-156-160-160-177-148-151
Other Financing Activities
-157-453-261-267-196-367-234-231-202-388-155-169-199-394-478-225-170-417-291-167
Financing Cash Flow
-704-830-999-2,967-3,089-1,495-2,163-110-1,093-1,216-1,039-1,132-1,198-725-1,838-2,317-1,926425-306-3,003

Net Cash Flow

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Foreign Exchange Rate Adjustments
-1-20-393-541-16-60713-16-12-51-7
Net Cash Flow
73-1004358-121-873-9552,057-453349442920-66-91141-1,513920424-93

Free Cash Flow

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
1,1048958703,1283,0346601,2742,3246901,3511,5151,3321,2346061,2041,8895504841,2511,388
Free Cash Flow Growth (YoY)
-63.61%35.61%-31.71%34.60%339.71%-51.15%-15.91%74.47%-44.08%122.94%25.83%-29.49%124.36%25.21%-3.76%36.09%-60.97%-63.72%--37.70%
FCF Margin
5.46%4.68%4.46%16.32%16.31%3.60%6.97%13.29%3.94%7.79%8.76%8.22%7.78%3.89%7.77%12.62%3.71%3.24%8.30%9.09%
Free Cash Flow Per Share
4.953.953.7713.2412.542.654.998.942.615.045.594.844.442.164.216.521.861.573.974.28
Levered Free Cash Flow
3,5451,8983,8902,2151,3801,6771,3773,7941,5591,3651,9641,7831,2693322,0592071,5113,3723,6162,302
Unlevered Free Cash Flow
2,5311,2262,6032,9412,267748.12,2532,3131,5111,2902,3942,0011,791233.041,5971,9971,069756.541,4472,325
SEC Filings: 10-K · 10-Q